Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034344
Filing Date
2024-11-12
Accepted
2024-11-12 08:44:09
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q crvo20240930_10q.htm   iXBRL 10-Q 1040435
2 EXHIBIT 31.1 ex_744569.htm EX-31.1 12188
3 EXHIBIT 31.2 ex_744570.htm EX-31.2 12087
4 EXHIBIT 32.1 ex_744571.htm EX-32.1 8287
5 EXHIBIT 32.2 ex_744572.htm EX-32.2 8399
11 crvo20240930_10qimg001.jpg GRAPHIC 7239
  Complete submission text file 0001437749-24-034344.txt   5257927

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240930.xsd EX-101.SCH 48704
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240930_def.xml EX-101.DEF 331288
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240930_lab.xml EX-101.LAB 287551
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240930_pre.xml EX-101.PRE 357030
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crvo-20240930_cal.xml EX-101.CAL 30907
70 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240930_10q_htm.xml XML 758162
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 241443816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)